12/11
01:23 pm
nvax
Why I Wouldn't Touch Novavax With a 10-Foot Pole [Yahoo! Finance]
Low
Report
Why I Wouldn't Touch Novavax With a 10-Foot Pole [Yahoo! Finance]
12/10
04:10 am
nvax
Novavax (NASDAQ:NVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Novavax (NASDAQ:NVAX) had its "sell (d)" rating reaffirmed by analysts at
Weiss Ratings.
12/5
05:15 pm
nvax
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
12/1
03:01 pm
nvax
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
Low
Report
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
12/1
12:17 pm
nvax
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
Low
Report
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
12/1
10:03 am
nvax
Moderna Falls as FDA Vows to Impose New Vaccine Requirements [Yahoo! Finance Canada]
Low
Report
Moderna Falls as FDA Vows to Impose New Vaccine Requirements [Yahoo! Finance Canada]
11/29
01:46 pm
nvax
FDA official, without providing data, claims link between COVID-19 vaccines and pediatric deaths [CBS News]
Medium
Report
FDA official, without providing data, claims link between COVID-19 vaccines and pediatric deaths [CBS News]
11/26
12:13 pm
nvax
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook [Seeking Alpha]
Low
Report
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax's Outlook [Seeking Alpha]
11/26
08:41 am
nvax
Novavax's R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX [Yahoo! Finance]
Medium
Report
Novavax's R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX [Yahoo! Finance]
11/25
08:51 am
nvax
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast [Yahoo! Finance]
Low
Report
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast [Yahoo! Finance]
11/21
02:16 pm
nvax
Novavax rises after a seven-day slide [Seeking Alpha]
Low
Report
Novavax rises after a seven-day slide [Seeking Alpha]
11/21
01:05 pm
nvax
Novamax rises after a seven-day slide [Seeking Alpha]
Low
Report
Novamax rises after a seven-day slide [Seeking Alpha]
11/18
11:04 am
nvax
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Low
Report
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
11/12
04:54 pm
nvax
Shah Capital pushes for Novavax sale, warns of proxy fight [Yahoo! Finance]
Low
Report
Shah Capital pushes for Novavax sale, warns of proxy fight [Yahoo! Finance]
11/12
08:00 am
nvax
Novavax to Participate in Jefferies London Healthcare Conference
Medium
Report
Novavax to Participate in Jefferies London Healthcare Conference
11/10
11:05 am
nvax
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, down previously from $18.00.
Low
Report
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, down previously from $18.00.
11/9
02:53 am
nvax
Examining the Changing Narrative for Novavax After Recent Partnerships and Strategic Shifts [Yahoo! Finance]
Medium
Report
Examining the Changing Narrative for Novavax After Recent Partnerships and Strategic Shifts [Yahoo! Finance]
11/8
01:17 pm
nvax
Medium
Report
11/6
08:00 am
nvax
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
Low
Report
Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
11/5
04:49 pm
nvax
A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX) [Yahoo! Finance]
Low
Report
A Look at Novavax's Valuation Following U.S. Vaccine Rights Transfer to Sanofi (NVAX) [Yahoo! Finance]
11/4
02:03 pm
nvax
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at TD Cowen from $8.00 to $7.00. They now have a "hold" rating on the stock.
Low
Report
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at TD Cowen from $8.00 to $7.00. They now have a "hold" rating on the stock.
11/4
07:00 am
nvax
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Medium
Report
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
10/30
08:00 am
nvax
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
Low
Report
Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025
10/25
11:32 pm
nvax
How the Narrative Around Novavax Is Shifting With New Partnerships and Strategic Changes [Yahoo! Finance]
Low
Report
How the Narrative Around Novavax Is Shifting With New Partnerships and Strategic Changes [Yahoo! Finance]
10/24
09:02 am
nvax
Novavax (NASDAQ:NVAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock.
Low
Report
Novavax (NASDAQ:NVAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock.